HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Clinical study on the time courses of serum myosin light chain I levels in patients with acute myocardial infarction: effect of intracoronary thrombolysis on serum myosin light chain I levels].

Abstract
Changes of serum myosin light chain I (Myosin LCI) concentrations and CK activities were serially measured in 23 patients with acute myocardial infarction. Intracoronary thrombolysis was performed in 14 patients (ICT group) while the remaining 9 patients were treated in the conventional manner (non ICT group). The relationships between the maximum levels of serum Myosin LCI or CK and a myocardial infarct size index or left ventricular function were evaluated in 18 patients. The myocardial infarct size index was determined by 201Tl myocardial scintigrams performed in the chronic phase. Multiple peaks of Myosin LCI were observed in 64% (9/14) of the ICT group and the first peak in 6 of these patients appeared Much earlier in the same time as CK peak than in the non-ICT group, while multiple peaks were seen only in one case in the non-ICT group. The infarct size index by 201Tl myocardial SPECT correlated with maximum Myosin LCI levels (r = 0.88, p < 0.001, n = 10) and CK activities (r = 0.67, p < 0.05, n = 10). These results indicate that the measurement of serum Myosin LCI is very useful for estimating the extent of myocardial damage and suggest that myocardial degeneration occurs at a very early phase of myocardial infarction.
AuthorsM Nakanishi, Y Saiki, K Ui, K Ohta, H Nozawa, J Kawai, E Tominaga, H Yamaguchi, H Ito, M Hino
JournalKaku igaku. The Japanese journal of nuclear medicine (Kaku Igaku) Vol. 29 Issue 12 Pg. 1479-88 (Dec 1992) ISSN: 0022-7854 [Print] Japan
PMID1491494 (Publication Type: English Abstract, Journal Article)
Chemical References
  • Myosin Light Chains
  • myosin light chain I
  • Myosins
Topics
  • Female
  • Humans
  • Male
  • Middle Aged
  • Myocardial Infarction (blood, drug therapy)
  • Myosin Light Chains
  • Myosins (blood)
  • Thrombolytic Therapy
  • Time Factors

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: